Profile data is unavailable for this security.
About the company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
- Revenue in CNY (TTM)736.03m
- Net income in CNY110.66m
- Incorporated1996
- Employees948.00
- LocationShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdZhangjiang Hi-tech ParkNo.308 Cailun RoadPudong District, Zhangjiang Hi-tech ParkSHANGHAI 201210ChinaCHN
- Phone+86 2 158553583
- Fax+86 2 158553893
- Websitehttp://www.fd-zj.com
More ▼
0.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 4.53m | 0.64% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.11m | 0.16% |
| Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 269.90k | 0.04% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 261.91k | 0.04% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 250.58k | 0.04% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 131.90k | 0.02% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 121.60k | 0.02% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 46.80k | 0.01% |
| Dimensional Fund Advisors Ltd.as of 31 May 2024 | 37.32k | 0.01% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 29.90k | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
